Partnership imminent for ONCS between now and the end of the year. Stay tuned.
I was just stating facts and quotes from Dr. Kim, nothing more.
You interpreted fear. If anything, because the stock has performed so poorly this year, it's due for a turnaround. That would be a different way of looking at it, right?
Different strokes for different folks.
What is your time horizon for someone putting money into a company to be categorized as an "investor?" One year? Five years? Twenty years? Other?
To me, investing is mostly about the ROI. IF you believe you can make more money by holding a very long time, that's great. IF you think you can make more money by swing trading, have at it.
For the record, I once held a substantial position in INO, but now only hold a few thousand shares. I believe it's a great investment longer-term, but better opportunities are out there now for the short-term. My largest position lies in ONCS, which I believe offers the best ROI between now and the end of the year. Let's see how the two companies perform between now and then, OK?
Your mileage in investing may vary.
Not exactly dwarfing is it?
Price on January 2nd: 11.48 (adjusted for reverse split)
Price on June 6th: 9.85 (first effective day of reverse split)
Closing price today: 9.86 (after our 15-yard penalty from Roche)
We're sitting exactly one penny greater than the starting reverse split price. Not exactly dwarfing is it?
Dr. Kim needs to tone down his loose rhetoric and funny sports analogies. No, he can use the sports analogies, as long as he completes and delivers on them.
I own both, but have a much larger position in ONCS because I believe it is a much better short-term play.
Longer-term, INO may be the better choice because of its larger pipeline.
Talks and Deals are two completely different things.
Punit has a lot on the line to deliver a deal by EOY and the industry is incredibly dynamic. Just look at what happened to INO today. (It will be interesting to see what Dr. Kim has to say at Stifel tomorrow.)
Still, I remain upbeat that a deal will get done before EOY. The million dollar question is "what kind of deal," and with whom...
The dots don't really exist (other than electroporation), but ONCS is certainly a better short-term investment.
Notwithstanding what Dr. Kim has to say tomorrow at the Stifel conference.
You obviously are not following the stock. It hasn't been that high for over 6 months. You probably couldn't even tell us the catalysts they have lined up over the next 3-5 weeks, could you. Could you?
How about five of them? How many does INO have in the next five weeks?
Yep, those 5 milestones aren't priced in (yet), but once we break through 0.60 the run-up will start in earnest. I expect 1.25+ by EOY.
No disagreement here. Long-term (2017 and beyond as you indicate), the future is bright for INO.
However, short-term, not so great. What happened to the "dwarfing in 2014," for example? The big money has already been made in the short-term (pre-2014). People talk about this thing selling for $50/share like it will happen tomorrow. I've got news for you. That probably won't happen until 2017 or beyond. We "might" see $15 by the end of 2015, IMHO. That's 50% from here, so that's still pretty good, but not what the pumpers expect you to believe.
If you want a 100+% return in 3 months, look no further than ONCS. Do your due diligence and see what you discover. You may be pleasantly surprised.
Well, you obviously haven't looked very far. ONCS is a FAR better short-term play than INO.
2015 will be filled with dilution for INO. About the best thing it has going in the short-term with actual results is the peer-reviewed paper. That won't move the stock. Only completed trials and partnerships will. And they just lost one of those.
Do REAL due diligence and forget the love affair. INO is definitely good longer-term, but not in the short-term. There are far better plays out there, and I just named one of them: ONCS.
You are correct. I am a moron in your mind. But you're just one.
Thousands think I'm not.
And yes, we're all legends in our own mind.
In the short-term ONCS has clearly more upside and ROI potential than does INO. Especially with the news that came out this morning.
ONCS will meet ALL of their remaining milestones for 2014 within the next 6 weeks. There will be positive PR every single week through the end of the year. We may very well see 100%+ gains from here through EOY.
I'm still invested in INO (for longer-term), but ONCS is where the real action is at the next 6 weeks.